P3 Health Partners Inc
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
PIII$4.25+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Description · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Form · File No. · Exhibit · Filing Date | |||||
| 2.1 | Agreement and Plan of Merger, dated as of May 25, 2021, by and between Foresight Acquisition Corp., P3 Health Group Holdings, LLC and FAC Merger Sub LLC. | 8-K | 001-40033 | 2.1 | 6/1/2021 |
| 2.2 | Transaction and Combination Agreement, dated as of May 25, 2021, by and among Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers. | 8-K | 001-40033 | 2.2 | 6/1/2021 |
| 2.3 | First Amendment to Merger Agreement, dated as of November 21, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC. | 8-K | 001-40033 | 2.1 | 11/22/2021 |
| 2.4 | Second Amendment, dated as of December 3, 2021, to the Agreement and Plan of Merger, dated as of May 25, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC. | 8-K | 001-40033 | 2.4 | 12/9/2021 |
| 2.5 | The First Amendment to the Transaction and Combination Agreement between Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers. | 8-K | 001-40033 | 2.5 | 12/9/2021 |
| 3.1 | Amended and Restated Certificate of Incorporation of the Company. | 8-K | 001-40033 | 3.1 | 12/9/2021 |
| 3.2 | Amended and Restated Bylaws of the Company. | 8-K | 001-40033 | 3.1 | 3/12/2024 |
| 4.1 | Form of Common Stock Purchase Warrant, dated May 24, 2024. | 8-K | 001-40033 | 4.1 | 5/24/2024 |
| 4.2 | Form of Pre-Funded Common Stock Purchase Warrant, dated May 24, 2024. | 8-K | 001-40033 | 4.2 | 5/24/2024 |
| 10.1† | Executive Employment Agreement, dated as of May 8, 2024, by and between P3 Health Partners Inc., P3 Health Group Management, LLC and Aric Coffman, M.D. | 8-K | 001-40033 | 10.1 | 5/9/2024 |
| 10.2† | P3 Health Partners Inc. 2024 Employment Inducement Incentive Award Plan. | 8-K | 001-40033 | 10.2 | 5/9/2024 |
| 10.3† | 2024 Employment Inducement Incentive Award Plan Form of Restricted Stock Unit Agreement. | S-8 | 333-279254 | 99.2 | 5/9/2024 |
| 10.4† | 2024 Employment Inducement Incentive Award Plan Form of Option Agreement. | S-8 | 333-279254 | 99.3 | 5/9/2024 |
| 10.5† | Stock Option Agreement under the 2024 Employment Inducement Incentive Award Plan, by and between P3 Health Partners Inc. and Aric Coffman, M.D. | 8-K | 001-40033 | 10.3 | 5/9/2024 |
| 10.6† | Restricted Stock Unit Agreement under the 2024 Employment Inducement Incentive Award Plan, by and between P3 Health Partners Inc. and Aric Coffman, M.D. | 8-K | 001-40033 | 10.4 | 5/9/2024 |
| 10.7 | Securities Purchase Agreement, dated May 22, 2024, by and among P3 Health Partners Inc. and the Purchasers named therein. | 8-K | 001-40033 | 10.1 | 5/24/2024 |
| 10.8 | Registration Rights Agreement, dated May 24, 2024, by and among P3 Health Partners Inc. and the Purchasers named therein. | 8-K | 001-40033 | 10.2 | 5/24/2024 |
| ExhibitNumber · Description · Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Form · File No. · Exhibit · Filing Date | ||||||
| 10.9 | Amended and Restated Letter Agreement, dated May 24, 2024, by and among P3 Health Partners Inc., Chicago Pacific Founders GP, L.P. and Chicago Pacific Founders GP III, L.P. | 8-K | 001-40033 | 10.3 | 5/24/2024 | |
| 10.10† | Consulting Agreement, dated as of May 8, 2024, by and between P3 Health Partners Inc., P3 Health Group Management, LLC and Sherif Abdou, M.D. | 8-K | 001-40033 | 10.5 | 5/9/2024 | |
| 31.1 | * | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 | * | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1 | ** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2 | ** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS | * | Inline XBRL Instance Document | ||||
| 101.SCH | * | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | * | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | * | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB | * | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE | * | Inline XBRL Taxonomy Extension Presentation Document | ||||
| 104 | * | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||
| * | Filed herewith |
|---|---|
| ** | Furnished herewith |
| † | Indicates management contract or compensatory plan |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.